These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 22052901

  • 1. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG, Bostic RR, Tong KB, Adamson R, Russo M, Slaughter MS.
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of continuous-flow left ventricular assist devices.
    Neyt M, Van den Bruel A, Smit Y, De Jonge N, Erasmus M, Van Dijk D, Vlayen J.
    Int J Technol Assess Health Care; 2013 Jul; 29(3):254-60. PubMed ID: 23763844
    [Abstract] [Full Text] [Related]

  • 3. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
    Health Quality Ontario.
    Ont Health Technol Assess Ser; 2016 Jul; 16(3):1-60. PubMed ID: 27026798
    [Abstract] [Full Text] [Related]

  • 4. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
    Long EF, Swain GW, Mangi AA.
    Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
    [Abstract] [Full Text] [Related]

  • 5. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW, Miller LW, Desvigne-Nickens P, Ascheim DD, Parides MK, Renlund DG, Oren RM, Krueger SK, Costanzo MR, Wann LS, Levitan RG, Mancini D, REMATCH Investigators.
    Circulation; 2004 Aug 24; 110(8):975-81. PubMed ID: 15313942
    [Abstract] [Full Text] [Related]

  • 6. Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure.
    Baras Shreibati J, Goldhaber-Fiebert JD, Banerjee D, Owens DK, Hlatky MA.
    JACC Heart Fail; 2017 Feb 24; 5(2):110-119. PubMed ID: 28017351
    [Abstract] [Full Text] [Related]

  • 7. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
    Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH, HeartMate II Investigators.
    J Am Coll Cardiol; 2009 Jul 21; 54(4):312-21. PubMed ID: 19608028
    [Abstract] [Full Text] [Related]

  • 8. Costs associated with ventricular assist device use in children.
    Mahle WT, Ianucci G, Vincent RN, Kanter KR.
    Ann Thorac Surg; 2008 Nov 21; 86(5):1592-7. PubMed ID: 19049755
    [Abstract] [Full Text] [Related]

  • 9. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.
    Health Technol Assess; 2005 Nov 21; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [Abstract] [Full Text] [Related]

  • 10. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.
    Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS, HeartMate II Investigators.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1826-34. PubMed ID: 20413033
    [Abstract] [Full Text] [Related]

  • 11. Economic Evaluation of Left Ventricular Assist Devices for Patients With End Stage Heart Failure Who Are Ineligible for Cardiac Transplantation.
    Chew DS, Manns B, Miller RJH, Sharma N, Exner DV.
    Can J Cardiol; 2017 Oct 27; 33(10):1283-1291. PubMed ID: 28941608
    [Abstract] [Full Text] [Related]

  • 12. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.
    J Thorac Cardiovasc Surg; 2010 Jul 27; 140(1):174-81. PubMed ID: 20447659
    [Abstract] [Full Text] [Related]

  • 13. Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation.
    Beese S, Avşar TS, Price M, Quinn D, Lim HS, Dretzke J, Ogwulu CO, Barton P, Jackson L, Moore D.
    Health Technol Assess; 2024 Aug 27; 28(38):1-237. PubMed ID: 39189844
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW.
    Circulation; 2007 Jul 31; 116(5):497-505. PubMed ID: 17638928
    [Abstract] [Full Text] [Related]

  • 15. Heart transplant and left ventricular assist device costs.
    Digiorgi PL, Reel MS, Thornton B, Burton E, Naka Y, Oz MC.
    J Heart Lung Transplant; 2005 Feb 31; 24(2):200-4. PubMed ID: 15701438
    [Abstract] [Full Text] [Related]

  • 16. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.
    Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE, Ewald GA, Sundareswaran KS, Farrar DJ, Slaughter MS, HeartMate II Clinical Investigators.
    Circ Heart Fail; 2012 Mar 01; 5(2):241-8. PubMed ID: 22282104
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
    Petrucci RJ, Rogers JG, Blue L, Gallagher C, Russell SD, Dordunoo D, Jaski BE, Chillcott S, Sun B, Yanssens TL, Tatooles A, Koundakjian L, Farrar DJ, Slaughter MS.
    J Heart Lung Transplant; 2012 Jan 01; 31(1):27-36. PubMed ID: 22153550
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure.
    Hutchinson J, Scott DA, Clegg AJ, Loveman E, Royle P, Bryant J, Colquitt JL.
    Expert Rev Cardiovasc Ther; 2008 Feb 01; 6(2):175-85. PubMed ID: 18248272
    [Abstract] [Full Text] [Related]

  • 20. Temporal changes in hospital costs for left ventricular assist device implantation.
    Slaughter MS, Bostic R, Tong K, Russo M, Rogers JG.
    J Card Surg; 2011 Sep 01; 26(5):535-41. PubMed ID: 21848578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.